[Coronary artery bypass grafting or percutaneous coronary intervention in patients with severe three vessel disease]

Gabriel Olivares R1, Nicolás Veas2

  • 1Servicio de Cirugía Cardiaca, Instituto Nacional del Tórax, Santiago, Chile.

Revista Medica De Chile
|March 23, 2022
PubMed

Insights

Coronary artery bypass grafting (CABG) offers better long-term survival and fewer repeat procedures than percutaneous coronary intervention (PCI) for severe coronary artery disease. The heart team should consider individual patient factors for optimal treatment decisions.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Severe three-vessel coronary artery disease and left main disease pose significant risks.
  • Percutaneous coronary intervention (PCI) addresses flow-limiting lesions.
  • Coronary artery bypass grafting (CABG) offers a more comprehensive approach to coronary artery disease.

Purpose of the Study:

  • To compare the long-term outcomes of CABG versus PCI in patients with severe coronary artery disease.
  • To evaluate the impact of revascularization strategy on survival and repeat procedures.
  • To emphasize the importance of a heart team approach in treatment selection.

Main Methods:

  • Review of recent randomized controlled trials.
  • Comparative analysis of clinical and anatomic factors.
  • Assessment of long-term survival, myocardial infarction, and repeat revascularization rates.

Main Results:

  • CABG demonstrated superior long-term survival compared to PCI.
  • CABG was associated with reduced rates of spontaneous myocardial infarction.
  • CABG showed lower rates of repeat revascularization compared to PCI.

Conclusions:

  • CABG is associated with improved long-term survival and reduced adverse events in severe coronary artery and left main disease.
  • CABG provides a more complete revascularization strategy, potentially preventing future cardiac events.
  • Personalized treatment recommendations by a heart team are crucial due to varying patient factors and outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
49
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
43
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
42
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
39
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
32